Five-year Kaplan-Meier estimates for the primary end point was 31.9 % in the chelation + high-dose vitamin group , 33.7 % in the chelation + placebo vitamin group , 36.6 % in the placebo infusion + active vitamin group , and 40.2 % in the placebo infusions + placebo vitamin group .